Glanbia Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| KO | Coca Cola | Outperform |
18
|
$62.17 | $65.84 | 9.38% | 4 | $267.83B |
| NESN | Nestlé | Outperform |
11
|
CHF91.72 | CHF115.58 | 19.93% | 13 | CHF240.43B |
| PEP | PepsiCo | Outperform |
18
|
$176.15 | $187.26 | 5.02% | 7 | $242.17B |
| ABT | Abbott Laboratories | Outperform |
9
|
$105.90 | $118.92 | 18.04% | 7 | $184.23B |
| ULVR | Unilever PLC | Hold |
8
|
£41.88 | £50.61 | 19.48% | 12 | £104.81B |
| GSK | GSK | Outperform |
12
|
£17.34 | £17.30 | 12.46% | 12 | £70.69B |
| 500696 | Hindustan Unilever | Outperform |
10
|
Rp2.22k | Rp2.75k | 14.20% | 1 | Rp5.21T |
| BAS | BASF | Outperform |
12
|
49.07€ | 49.50€ | 14.12% | 2 | 43.80€B |
| LONN | Lonza Group | Buy |
16
|
CHF519.60 | CHF516.89 | 14.51% | 8 | CHF37.47B |
| GIVN | Givaudan | Hold |
14
|
CHF3.99k | CHF3.14k | -3.56% | 8 | CHF36.84B |
| BN | Danone | Outperform |
11
|
57.74€ | 55.47€ | 10.84% | 2 | 37.06€B |
| GIS | General Mills Inc | Hold |
18
|
$69.91 | $68.63 | 2.27% | 13 | $39.47B |
| DSFIR | DSM-Firmenich | Outperform |
18
|
104.60€ | 114.60€ | 14.72% | 0 | 27.75€B |
| NZYM B | Novozymes A/S | Outperform |
18
|
kr412.20 | kr365.54 | 9.17% | 4 | kr191.51B |
| IFF | International Flavors & Fragra... | Hold |
15
|
$86.64 | $84.46 | 0.99% | 17 | $22.12B |
| K | Kellanova | Hold |
13
|
$60.51 | $59.19 | 1.64% | 10 | $20.69B |
| MKC | McCormick & Company | Hold |
12
|
$75.45 | $72.03 | -0.60% | 1 | $20.08B |
| CELH | Celsius Holdings | Outperform |
13
|
$75.97 | $68.64 | 25.05% | 5 | $17.71B |
| SY1 | Symrise | Outperform |
18
|
100.75€ | 106.97€ | 11.17% | 5 | 14.08€B |
| DABUR | Dabur India | Outperform |
18
|
Rp531.75 | Rp607.25 | 12.83% | 27 | Rp942.28B |
| CHR | Chr. Hansen Holding A/S | - |
16
|
kr549.60 | kr71.11 | -100.00% | 0 | kr72.33B |
| BARN | Barry Callebaut | Outperform |
18
|
CHF1.53k | CHF1.88k | 1.64% | 0 | CHF8.12B |
| SMPL | Simply Good Foods Co-The | Outperform |
15
|
$37.34 | $40.58 | 8.46% | 1 | $3.64B |
| GRG | Greggs | Outperform |
18
|
£27.22 | £32.27 | 20.06% | 0 | £2.75B |
| TATE | Tate & Lyle | Outperform |
16
|
£6.55 | £8.58 | 29.77% | 2 | £2.62B |
| SXT | Sensient Technologies | Buy |
18
|
$74.00 | $72.00 | 6.76% | 1 | $3.10B |
| CWK | Cranswick | Buy |
18
|
£42.35 | £44.24 | 8.15% | 9 | £2.33B |
| BVIC | Britvic | Outperform |
18
|
£8.84 | £9.82 | 11.43% | 8 | £2.19B |
| FCG | Fonterra Co-operative Group | - |
16
|
$2.21 | $0.00 | -100.00% | 0 | $4.19B |
| ARYN | ARYZTA | Buy |
10
|
CHF1.77 | CHF2.23 | 25.99% | 2 | CHF1.73B |
| PFD | Premier Foods | Buy |
16
|
£1.61 | £1.65 | 24.22% | 5 | £1.40B |
| CRBN | Corbion N.V. | Outperform |
14
|
20.94€ | 24.42€ | 19.39% | 5 | 1.21€B |
| HFG | Hilton Food Group | Buy |
16
|
£9.21 | £8.91 | 11.83% | 1 | £820.76M |
| HLF | Herbalife | Outperform |
16
|
$9.58 | $17.90 | 4.38% | 4 | $937.70M |
| BAKK | Bakkavor Group | Outperform |
18
|
£1.20 | £1.07 | 2.50% | 1 | £695.58M |
| CCR | C&C Group | Buy |
6
|
£1.67 | £2.38 | 33.53% | 3 | £640.89M |
| BAG | A.G. BARR p.l.c. | Buy |
18
|
£5.75 | £5.97 | 16.17% | 3 | £633.70M |
| GNC | Greencore Group | Outperform |
15
|
£1.33 | £1.04 | -18.80% | 4 | £607.60M |
| FSTA | Fuller, Smith & Turner P.L.C. | Hold |
13
|
£6.16 | £7.20 | 7.14% | 3 | £353.95M |
| NICL | Nichols | Outperform |
16
|
£9.54 | £11.57 | 26.31% | 0 | £348.46M |
| MED | Medifast | Hold |
18
|
$26.69 | $69.50 | -6.33% | 2 | $277.33M |
| RELV | Reliv' International | - |
0
|
$4.06 | $21.00 | -100.00% | 0 | $5.55M |
| 542910 | Valencia Nutrition | - |
0
|
Rp78.00 | Rp0.00 | -100.00% | 0 | Rp76.52M |
| ERGO | Entia Biosciences | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| MSLP.Q | MusclePharm | - |
0
|
$0.00 | $1.65 | 0.00% | 0 | $0.00M |